Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$145.6 - $158.88 $82,992 - $90,561
570 Added 1.94%
30,006 $4.7 Million
Q3 2023

Oct 12, 2023

BUY
$155.75 - $174.48 $24,452 - $27,393
157 Added 0.54%
29,436 $4.58 Million
Q2 2023

Jul 14, 2023

BUY
$154.35 - $166.11 $39,359 - $42,358
255 Added 0.88%
29,279 $4.85 Million
Q1 2023

Apr 13, 2023

SELL
$151.05 - $180.26 $425,961 - $508,333
-2,820 Reduced 8.86%
29,024 $4.5 Million
Q4 2022

Jan 11, 2023

SELL
$160.2 - $179.79 $483,163 - $542,246
-3,016 Reduced 8.65%
31,844 $0
Q3 2022

Oct 11, 2022

BUY
$161.33 - $179.52 $180,689 - $201,062
1,120 Added 3.32%
34,860 $5.7 Million
Q2 2022

Jul 08, 2022

SELL
$168.19 - $186.01 $179,122 - $198,100
-1,065 Reduced 3.06%
33,740 $5.99 Million
Q1 2022

Apr 19, 2022

BUY
$158.14 - $179.59 $32,418 - $36,815
205 Added 0.59%
34,805 $6.17 Million
Q4 2021

Jan 12, 2022

BUY
$155.93 - $173.01 $190,546 - $211,418
1,222 Added 3.66%
34,600 $5.92 Million
Q3 2021

Oct 12, 2021

BUY
$161.5 - $179.47 $193,638 - $215,184
1,199 Added 3.73%
33,378 $5.39 Million
Q2 2021

Aug 10, 2021

SELL
$159.48 - $171.07 $129,019 - $138,395
-809 Reduced 2.45%
32,179 $5.3 Million
Q1 2021

May 11, 2021

BUY
$153.07 - $170.48 $169,601 - $188,891
1,108 Added 3.48%
32,988 $5.42 Million
Q4 2020

Jan 21, 2021

BUY
$137.11 - $157.38 $218,827 - $251,178
1,596 Added 5.27%
31,880 $5.02 Million
Q3 2020

Oct 20, 2020

BUY
$140.38 - $153.83 $342,246 - $375,037
2,438 Added 8.76%
30,284 $4.51 Million
Q2 2020

Aug 14, 2020

BUY
$128.81 - $155.51 $288,276 - $348,031
2,238 Added 8.74%
27,846 $3.92 Million
Q1 2020

Apr 17, 2020

BUY
$111.14 - $153.99 $26,340 - $36,495
237 Added 0.93%
25,608 $3.36 Million
Q4 2019

Jan 30, 2020

BUY
$127.5 - $146.44 $3.23 Million - $3.72 Million
25,371 New
25,371 $3.7 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ayrshire Capital Management LLC Portfolio

Follow Ayrshire Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ayrshire Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ayrshire Capital Management LLC with notifications on news.